Spatial and temporal expression of CCR3 and the common beta chain of the IL-3, IL-5 and GM-CSF receptor in the nasal epithelium and lymphoid tissues in a rat model of allergic rhinitis

Cytokine

Volumn 52, Issue 3, 2010, Pages 194-202

  Fortin, Marylène ^a,d   Wagner, James G ^b   Brault, Julie ^a   Harkema, Jack R ^b   Renzi, Paolo M ^a,c   Paquet, Luc ^a   Ferrari, Nicolay ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c NOTRE DAME HOSPITAL   (Canada)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Allergic rhinitis; Beta chain; CCR3; Inflammation; Nasal mucosa

Indexed keywords

ALLERGEN; CHEMOKINE RECEPTOR CCR3; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 5; MESSENGER RNA; MUCIN 5AC; TUMOR NECROSIS FACTOR ALPHA; CCR3 PROTEIN, RAT; PRIMER DNA;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA CHAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; EOSINOPHIL; HISTOPATHOLOGY; LYMPHOID TISSUE; MALE; NONHUMAN; NOSE MUCOSA; NOSE SEPTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; TURBINATE; UPREGULATION; ANIMAL; DISEASE MODEL; GENETICS; HYPERSENSITIVITY; METABOLISM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RHINITIS;

ANIMALIA; RATTUS;

ANIMALS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA PRIMERS; HYPERSENSITIVITY; INTERLEUKIN-3; INTERLEUKIN-5; LYMPHOID TISSUE; MALE; NASAL MUCOSA; POLYMERASE CHAIN REACTION; RATS; RECEPTORS, CCR3; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; RHINITIS; RNA, MESSENGER;

EID: 79953302461     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.07.005     Document Type: Article

References (57)

1. Bousquet J., Vignola A.M., Demoly P. Links between rhinitis and asthma. Allergy 2003, 58:691-706.
2. Jeffery P., Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med 2006, 6:S5.
3. Gelfand E.W. Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol 2004, 114:S135-S138.
4. Simons F. Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol 1999, 104:534-540.
5. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003, 111:1171-1183.
6. Bousquet J., Van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147-S334.
7. Leynaert B., Bousquet J., Neukirch C., Liard R., Neukirch F. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999, 104:301-304.
8. Iwasaki M., Saito K., Takemura M., Sekikawa K., Fujii H., Yamada Y., et al. TNF-[α] contributes to the development of allergic rhinitis in mice. J Allergy Clin Immunol 2003, 112:134-140.
9. Shirasaki H., Watanabe K., Kanaizumi E., Sato J., Konno N., Narita S., et al. Effect of glucocorticosteroids on tumour necrosis factor-α-induced intercellular adhesion molecule-1 expression in cultured primary human nasal epithelial cells. Clin Exp Allergy 2004, 34:945-951.
10. Jankowski R., Persoons M., Foliguet B., Coffinet L., Thomas C., Verient-Montaut B. Eosinophil count in nasal secretions of subjects with and without nasal symptoms. Rhinology 2000, 38:23-32.
11. Kramer M.F., Jordan T.R., Klemens C., Hilgert E., Hempel J.M., Pfrogner E., et al. Factors contributing to nasal allergic late phase eosinophilia. Am J Otolaryngol 2006, 27:190-199.
12. Eliashar R., Levi-Schaffer F. The role of the eosinophil in nasal diseases. Curr Opin Otolaryngol Head Neck Surg 2005, 13:171-175.
13. Gleich G.J. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990, 85:422-436.
14. Gleich G.J., Adolphson C.R., Leiferman K.M. The biology of the eosinophilic leukocyte. Annu Rev Med 1993, 44:85-101.
15. Rothenberg M.E., Hogan S.P. The eosinophil. Annu Rev Immunol 2006, 24:147-174.
16. Combadiere C., Ahuja S.K., Murphy P.M. Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem 1995, 270:16491-16494.
17. Griffiths-Johnson D., Collins P., Rossi A., Jose P., Williams T. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 1993, 197:1167-1172.
18. Jose P.J., Griffiths-Johnson D.A., Collins P.D., Walsh D.T., Moqbel R., Totty N.F., et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. Tokyo Joshi-Idai Asthma Research Group. J Exp Med 1994, 179:881-887.
19. Yang M., Hogan S.P., Mahalingam S., Pope S.M., Zimmermann N., Fulkerson P., et al. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J Allergy Clin Immunol 2003, 112:935-943.
20. Tavernier J., Van der Heyden J., Verhee A., Brusselle G., Van Ostade X., Vandekerckhove J., et al. Interleukin 5 regulates the isoform expression of its own receptor α-subunit. Blood 2000, 95:1600-1607.
21. Kitamura T., Sato N., Arai K., Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 1991, 66:1165-1174.
22. Tamaoki J., Kondo M., Sakai N., Aoshiba K., Tagaya E., Nakata J., et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Lancet 2000, 356:273-278.
23. O'Byrne P.M. Cytokines or their antagonists for the treatment of asthma. Chest 2006, 130:244-250.
24. Haldar P., Brightling C.E., Hargadon B., Gupta S., Monteiro W., Sousa A., et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009, 360:973-984.
25. Nair P., Pizzichini M.M.M., Kjarsgaard M., Inman M.D., Efthimiadis A., Pizzichini E., et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009, 360:985-993.
26. Holse M., Assing K., Poulsen L.K. CCR3, CCR5, CCR8 and CXCR3 expression in memory T helper cells from allergic rhinitis patients, asymptomatically sensitized and healthy individuals. Clin Mol Allergy 2006, 4:6-12.
27. Joubert P., Lajoie-Kadoch S., Labonte I., Gounni A.S., Maghni K., Wellemans V., et al. CCR3 expression and function in asthmatic airway smooth muscle cells. J Immunol 2005, 175:2702-2708.
28. Kato Y., Pawankar R., Kimura Y., Kawana S. Increased expression of RANTES, CCR3 and CCR5 in the lesional skin of patients with atopic eczema. Int Arch Allergy Immunol 2006, 139:245-257.
29. Liu L., Jarjour N., Busse W., Kelly E. Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental antigen challenge. J Allergy Clin Immunol 2003, 112:556-562.
30. Lun S., Wong C., Ko F., Ip W., Hui D., Lam C. Aberrant expression of CC and CXC chemokines and their receptors in patients with asthma. J Clin Immunol 2006, 26:145-152.
31. Oyamada H., Kamada Y., Kuwasaki T., Yamada Y., Kobayashi Y., Cui C., et al. CCR3 mRNA expression in bronchial epithelial cells and various cells in allergic inflammation. Int Arch Allergy Immunol 1999, 120:45-47.
32. Allakhverdi Z., Allam M., Guimond A., Ferrari N., Zemzoumi K., Seguin R., et al. Multitargeted approach using antisense oligonucleotides for the treatment of asthma. Ann NY Acad Sci 2006, 1082:62-73.
33. Elsner J., Escher S.E., Forssmann U. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy 2004, 59:1243-1258.
34. Fortin M., Ferrari N., Higgins M.-E., Seguin S., Allam M., Allakhverdi Z., et al. Effects of antisense oligodeoxynucleotides targeting CCR3 on the airway response to antigen in rats. Oligonucleotides 2006, 16:203-212.
35. Senechal S., Fahy O., Gentina T., Vorng H., Capron M., Walls A., et al. CCR3-blocking antibody inhibits allergen-induced eosinophil recruitment in human skin xenografts from allergic patients. Lab Invest 2002, 82:929-939.
36. Wegmann M., Goggel R., Sel S., Sel S., Erb K.J., Kalkbrenner F., et al. Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma. Am J Respir Cell Mol Biol 2007, 36:61-67.
37. Das A.M., Vaddi K.G., Solomon K.A., Krauthauser C., Jiang X., McIntyre K.W., et al. Selective inhibition of eosinophil influx into the lung by small molecule CC chemokine receptor 3 antagonists in mouse models of allergic inflammation. J Pharmacol Exp Ther 2006, 318:411-417.
38. Allakhverdi Z., Allam M., Renzi P.M. Inhibition of antigen-induced eosinophilia and airway hyperresponsiveness by antisense oligonucleotides directed against the common beta chain of IL-3, IL-5, GM-CSF receptors in a rat model of allergic asthma. Am J Respir Crit Care Med 2002, 165:1015-1021.
39. Gauvreau G.M., Boulet L.P., Cockcroft D.W., Baatjes A., Cote J., Deschesnes F., et al. Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Am J Respir Crit Care Med 2008, 177:952-958.
40. Wagner J.G., Harkema J.R. Rodent models of allergic rhinitis: relevance to human pathophysiology. Curr Allergy Asthma Rep 2007, 7:134-140.
41. Harkema J., Plopper C., Hyde D., St George J., Dungworth D. Effects of an ambient level of ozone on primate nasal epithelial mucosubstances. Quantitative histochemistry. Am J Pathol 1987, 127:90-96.
42. Wagner J.G., Hotchkiss J.A., Harkema J.R. Enhancement of nasal inflammatory and epithelial responses after ozone and allergen coexposure in brown Norway rats. Toxicol Sci 2002, 67:284-294.
43. Shim J.J., Dabbagh K., Ueki I.F., Dao-Pick T., Burgel P.-R., Takeyama K., et al. IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol 2001, 280:L134-L140.
44. Whittaker L., Niu N., Temann U.A., Stoddard A., Flavell R.A., Ray A., et al. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T Cells and interleukin-9. Am J Respir Cell Mol Biol 2002, 27:593-602.
45. Harkema J., Carey S., Wagner J. The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium. Toxicol Pathol 2006, 34:252-269.
46. Farraj A.K., Harkema J.R., Kaminski N.E. Allergic rhinitis induced by intranasal sensitization and challenge with trimellitic anhydride but not with dinitrochlorobenzene or oxazolone in A/J mice. Toxicol Sci 2004, 79:315-325.
47. Wagner J.G., Van Dyken S.J., Wierenga J.R., Hotchkiss J.A., Harkema J.R. Ozone exposure enhances endotoxin-induced mucous cell metaplasia in rat pulmonary airways. Toxicol Sci 2003, 74:437-446.
48. Humbert M., Ying S., Corrigan C., Menz G., Barkans J., Pfister R., et al. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am J Respir Cell Mol Biol 1997, 16:1-8.
49. Ying S., Meng Q., Zeibecoglou K., Robinson D.S., Macfarlane A., Humbert M., et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and CC chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999, 163:6321-6329.
50. Zhang R.X., Yu S.Q., Jiang J.Z., Liu G.J. Complementary DNA microarray analysis of chemokines and their receptors in allergic rhinitis. J Investig Allergol Clin Immunol 2007, 17:329-336.
51. Durham S.R., Ying S., Varney V.A., Jacobson M.R., Sudderick R.M., Mackay I.S., et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992, 148:2390-2394.
52. Terada N., Konno A., Fukuda S., Yamashita T., Shirotori K., Okamoto Y., et al. Interleukin-5 gene expression in nasal mucosa and changes in amount of interleukin-5 in nasal lavage fluid after antigen challenge. Acta Otolaryngol 1994, 114:203-208.
53. Casale T.B., Stokes J.R. Immunomodulators for allergic respiratory disorders. J Allergy Clin Immunol 2008, 121:288-296.
54. Terada N., Hamano N., Kim W.J., Hirai K., Nakajima T., Yamada H., et al. The kinetics of allergen-induced eotaxin level in nasal lavage fluid. Its key role in eosinophil recruitment in nasal mucosa. Am J Respir Crit Care Med 2001, 164:575-579.
55. Fiset P.O., Soussi-Gounni A., Christodoulopoulos P., Tulic M., Sobol S.E., Frenkiel S., et al. Modulation of allergic response in nasal mucosa by antisense oligodeoxynucleotides for IL-4. J Allergy Clin Immunol 2003, 111:580-586.
56. Bitko V., Barik S. Intranasal antisense therapy: preclinical models with a clinical future?. Curr Opin Mol Ther 2007, 9:119-125.
57. Griesenbach U., Kitson C., Escudero Garcia S., Farley R., Singh C., Somerton L., et al. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. Respir Res 2006, 7:26-41.